Pirepemat
Pirepemat (IRL752) is a corticalpreferring catecholamine- and cognition-promoting agent. Pirepemat (IRL752) is used for the study of Parkinson's disease. IRL752 is a selective enhancer of cortical dopamine, acetylcholine and norepinephrine.
For research use only. We do not sell to patients.
- CAS No.: 1227638-29-0
- Formula: C11H13F2NO
- Molecular Weight:213.22
-
Storage:Pure form -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
IRL752 displayed its highest in vitro affinities for 5-HT and NA-related targets[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Normal rats[2].
-
Dosage:3.7-100 µmol/kg.
-
Administration:s.c., 30 min prior to testing.
-
Result:Induced dose-dependent and regio-selective alterations in brain monoamine transmission indices and gene expression.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 1227638-29-0
-
Appearance Oil
-
Molecular Weight 213.22
-
Formula C11H13F2NO
-
Color Off-white to brown
-
SMILES
CO[C@]1(C(C=CC=C2F)=C2F)CCNC1
-
Synonyms
IRL752
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Pure form -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Purity & Documentation
-
Data Sheet (275 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
[1]. Systematic review of pharmacological interventions for people with Lewy body dementia
[3]. S Hjorth, et al. (3 S)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine (IRL752) -a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting Agent. J Pharmacol Exp Ther. 2020 Sep;374(3):404-419. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)